LP
RNAM

LMR Partners’s Avidity Biosciences RNAM Stock Holding History

LMR Partners’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-598,525
Closed -$43.2M – 1803
2025
Q4 		$43.2M Buy
+598,525
New +$38.7M 0.08% 110

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

LMR Partners's RNAM Position: Q1 2026 in Review

LMR Partners sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 598,525 shares — an estimated $43.2M sold.

LMR Partners first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $43.2M in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • LMR Partners reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • LMR Partners sold 598,525 Avidity Biosciences shares in Q1 2026, an estimated $43.2M.
  • LMR Partners first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • LMR Partners's Avidity Biosciences position peaked at $43.2M in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on LMR Partners's 13F filing for Q1 2026, filed 15 May 2026.